Metagenomi Therapeutics, Inc. (MGX)

NASDAQ: MGX · Real-Time Price · USD

1.390

+0.020 (1.46%)

At close: Mar 25, 2026, 4:00 PM EDT

1.400

+0.010 (0.72%)

After-hours: Mar 25, 2026, 5:26 PM EDT

Metagenomi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.72	27.39	140.6	184.44	39.3
Short-Term Investments	119.08	220.92	130.58	177.69	68.86
Cash & Short-Term Investments	160.8	248.31	271.18	362.13	108.15
Cash Growth	-35.24%	-8.43%	-25.11%	234.83%	-
Accounts Receivable	0.31	1.26	2.45	-	-
Other Receivables	-	-	-	1.27	-
Total Trade Receivables	0.31	1.26	2.45	1.27	-
Other Current Assets	4.43	8.4	4.64	3.49	0.76
Total Current Assets	165.54	257.96	278.27	366.9	108.92
Net Property, Plant & Equipment	47.38	57.66	65.15	33.26	21.89
Long-Term Investments	2.15	3.45	10.68	7.81	6.42
Other Long-Term Assets	6.03	5.54	10.74	6.52	4.77
Total Assets	221.1	324.6	364.84	414.49	141.99
Accounts Payable	1.49	0.53	1.79	2.01	1.35
Accrued Expenses	6.72	8.42	11.47	8.79	3.53
Current Portion of Leases	6.03	5.59	3.43	1.52	0.69
Unearned Revenue	8.7	22.76	48.91	34.69	19.6
Other Current Liabilities	-	-	3.27	1.54	-
Total Current Liabilities	22.93	37.31	68.86	48.54	25.17
Long-Term Debt	-	-	-	-	30.28
Long-Term Leases	34.63	40.19	44.8	17.06	17.97
Other Long-Term Liabilities	4.94	12.25	36.01	77.22	24.63
Total Long-Term Liabilities	39.57	52.43	80.81	94.27	72.87
Total Liabilities	62.51	89.74	149.67	142.81	98.04
Common Stock	0	0	-	0.03	0.03
Additional Paid-in Capital	469.2	457.15	9.46	2.51	0.55
Accumulated Other Comprehensive Income	0.26	0.71	-0.1	-0.27	-0.02
Retained Earnings	-310.87	-223	-144.94	-76.69	-33.1
Total Common Shareholders' Equity	158.6	234.86	-135.58	-74.43	-32.54
Minority Interest	-	-	350.76	346.1	76.5
Shareholders' Equity	158.6	234.86	215.17	271.68	43.95
Total Liabilities & Equity	221.1	324.6	364.84	414.49	141.99
Total Debt	40.66	45.78	48.23	18.57	48.93
Net Cash (Debt)	120.14	202.53	222.95	343.56	59.23
Net Cash Growth	-40.68%	-9.16%	-35.10%	480.08%	-
Net Cash Per Share	3.23	6.13	65.49	101.06	-
Book Value	158.6	234.86	-135.58	-74.43	-32.54
Book Value Per Share	4.26	7.11	-39.82	-21.89	-
Tangible Book Value	158.6	234.86	-135.58	-74.43	-32.54
Tangible Book Value Per Share	4.26	7.11	-39.82	-21.89	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q